Claims
- 1. Method for maintaining normal blood pressure, comprising administering to a subject glycine betaine in an amount sufficient to achieve the desired result.
- 2. The method according to claim 1, wherein a daily dosage of 0.05-20 g of glycine betaine is administered.
- 3. The method according to claim 1, wherein a daily dosage of 0.1-8 g per day of added glycine is administered.
- 4. The method according to claim 1, wherein glycine betaine is in the form of anhydride, monohydrate, or a salt.
- 5. Method for reducing blood pressure, comprising administering to a subject glycine betaine in an amount sufficient to achieve the desired result.
- 6. The method according to claim 5, wherein a daily dosage of 0.05-20 g of glycine betaine is administered.
- 7. The method according to claim 5, wherein a daily dosage of 0.1-8 g per day of added glycine is administered.
- 8. The method according to claim 5, wherein glycine betaine is in the form of anhydride, monohydrate, or a salt.
- 9. The method according to claim 5, wherein the reduction of diastolic pressure is achieved.
- 10. Method for the prevention or treatment of hypertension, comprising administering to a subject in need of such treatment glycine betaine in an amount sufficient to achieve the desired result.
- 11. The method according to claim 10, wherein a daily dosage of 0.05-20 g of glycine betaine is administered.
- 12. The method according to claim 10, wherein a daily dosage of 0.1-8 g per day of added glycine is administered.
- 13. The method according to claim 10, wherein glycine betaine is in the form of anhydride, monohydrate, or a salt.
- 14. The method according to claim 10, wherein a daily dosage of 0.05-20 g of glycine betaine is provided.
- 15. The method according to claim 10, wherein a daily dosage of 0.1-8 g per day of added glycine is provided.
- 16. The method according to claim 10, wherein the added glycine betaine is in the form of anhydride, monohydrate, or a salt.
- 17. The method according to claim 10, wherein the reduction of diastolic pressure is achieved.
Priority Claims (1)
Number |
Date |
Country |
Kind |
20010075 |
Jan 2001 |
FI |
|
Parent Case Info
[0001] This application is a Continuation of International Application PCT/FI02/00024 filed on Nov. 1, 2002, which designated the U.S. and was published under PCT Article 21(2) in English.
Continuations (1)
|
Number |
Date |
Country |
Parent |
PCT/FI02/00024 |
Jan 2002 |
US |
Child |
10617974 |
Jul 2003 |
US |